8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):  February 7, 2007

MWI VETERINARY SUPPLY, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-51468	02-0620757
(State or other jurisdiction of Incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)

651 S. Stratford Drive, Suite 100, Meridian, ID   83642

(Address of principal executive offices)   (Zip Code)

(800) 824-3703

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

oWritten communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

oSoliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

oPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

oPre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 7.01  Regulation FD Disclosure.

Attached as exhibit 99.1 and furnished for purposes of Regulation FD is an Investor Presentation to be given by MWI Veterinary Supply, Inc. (the “Company”) at the Company’s annual meeting of stockholders that will be held on February 7, 2007 in Boise, Idaho.

Attached as exhibit 99.2 and furnished for purposes of Regulation FD is an Investor Presentation to be given by the Company at the William Blair & Company Winter Conference that will be held February 7-11, 2007 in Aspen, Colorado and the UBS Global Healthcare Services Conference that will be held February 12-14 in New York, New York.

The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.

Item 9.01.  Financial Statements and Exhibits

(d)       Exhibits

The following exhibits relating to Item 7.01 shall be deemed to be furnished, and not filed:

99.1         MWI Veterinary Supply, Inc. Annual Meeting Investor Presentation.

99.2         MWI Veterinary Supply, Inc. February 2007 Conference Investor Presentation.

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		MWI VETERINARY SUPPLY, INC.
Date:  February 7, 2007	By	/s/ Mary Patricia B. Thompson
		Mary Patricia B. Thompson
		Senior Vice President of Finance and Administration, Chief Financial Officer

3

EXHIBIT INDEX

Exhibit No.	Description
99.1	MWI Veterinary Supply, Inc. Annual Meeting Investor Presentation.
99.2	MWI Veterinary Supply, Inc. February 2007 Conference Investor Presentation.

4

EX-99.1

Exhibit 99.1

2007 ANNUAL STOCKHOLDERS’ MEETING

MWI Company Overview and Fiscal Year 2006 Review Jim Cleary Mary Pat Thompson

Disclaimer/Forward-Looking Statements This presentation may contain forward-looking statements based on current management expectations. Numerous factors, including those related to market conditions and those detailed in our Annual Report on Form 10-K, may cause results to differ materially from those anticipated in forward-looking statements. Many of the factors that will determine the Company’s future results are beyond the ability of the Company to control or predict. These statements are subject to risks and uncertainties and, therefore, actual results may differ materially. Potential investors should not place undue reliance on forward-looking statements, which reflect management’s views only as of the date hereof. The Company undertakes no obligation to revise or update any forward looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

MWI Mission Statement MWI will be the best resource to the veterinary profession by delivering superior value, efficiency and innovation.

MWI Core Values MWI’s culture is driven by our five core values of customer service, integrity, dedication, innovation and quality. With a history of 30 years in veterinary distribution, we believe we have developed a strong culture and business model for the future.

Our Company Leading distributor of animal health products to veterinarians across U.S. 30 years of operating history 15,000+ veterinary practices nationwide 10,000+ products sourced from 400+ vendors Strong financial performance

MWI Locations

MWI’s Revenue Mix Companion Animal, 2/3 Production Animal, 1/3

The MWI Edge: Broad Product Portfolio Over 10,000 products stocked in MWI warehouses Over 7,000 additional products available by special order Continually evaluate product portfolio to improve offerings Key products include: Pharmaceuticals, Vaccines and Parasiticides Diagnostics, Capital Equipment and Supplies Veterinary Pet Food and Nutritional Products

The MWI Edge: Broad Product Portfolio 40% 19% 7% 8% 3% 23% Pharmaceuticals Vaccines Parasiticides Diagnostics Capital Equipment Other Supplies

The MWI Edge: Premier Sales and Marketing Franchise Sales Representatives Direct Marketing Dual coverage approach with frequent contact Act as business consultants Continuous training initiatives Performance driven compensation Significant industry experience Over 450,000 pieces of direct marketing material distributed Comprehensive and specialty catalogs, loyalty programs, product/vendor programs, flyers, order stuffers 69 75 79 93 106 94 111 134 155 82 2002 2003 2004 2005 2006 Telesales Reps Field Sales Reps

The MWI Edge: Innovative Technology Systems Technology systems closely integrated with customers’ day-to-day operations E-commerce System Inventory Management System

MWI Growth Strategies Expand Number of Veterinarians Served Offer Innovative, Differentiated Solutions to Veterinarians Increase Share of Wallet from Existing Customers Pursue Strategic Acquisitions Expand Agreements with Existing and New Vendors Increase Overall Productivity and Profitability

Revenues of $606 million Plus an additional $151 million of sales of agency products Merger and integration of Northland Veterinary Supply, Ltd. Expansion of our Harrisburg, Pennsylvania and Denver, Colorado distribution facilities Opening our 12th distribution facility in Orlando, Florida Growth of value-added services: E-commerce platform Sweep™ inventory management system Pharmacy fulfillment program Capital equipment consulting Follow on offering of MWI’s common stock resulting in net proceeds of approximately $27.3 million MWI Headline News in Fiscal Year 2006

What’s in store for Fiscal Year 2007 We relocated to a new, larger distribution center in Atlanta, Georgia in January 2007 Evaluation of additional a new distribution center in the Midwest Expansion of our sales force into new sales territories as well as into our mature regions Continued focus on value-added services: E-commerce platform Sweep™ inventory management system Pharmacy fulfillment program Capital equipment consulting Evaluation of strategic acquisitions

Financial Overview Mary Pat Thompson

Total Revenues FY 2001 - 2006 CAGR 22.3% Strong Growth in Revenues Dollars in millions $606.2 $496.7 $394.3 $341.7 $281.2 $221.4 $0 $100 $200 $300 $400 $500 $600 $700 2001 2002 2003 2004 2005 2006

Operating Income FY 2001 - 2006 CAGR 26.5% Strong Growth in Operating Income Dollars in millions $23.7 $15.8 $12.6 $10.2 $7.2 $7.3 $0 $4 $8 $12 $16 $20 $24 2001 2002 2003 2004 2005 2006

Condensed Consolidated Balance Sheet ($ in thousands) Assets 09/30/06 09/30/05   Cash $ 37 $ 31 Receivables, net 99,518 77,099 Inventories 85,083 68,786 Other current assets 3,153 2,493 Total Current Assets 187,791 148,409   Property and equipment, net 7,053 6,919 Goodwill & intangibles, net 33,943 31,383 Other assets, net 1,772   1,533 Total Assets $ 230,559   $ 188,244   Liabilities   Line-of-credit $ 10,559 $ 24,690 Accounts payable 82,561 69,382 Accrued expenses & other current liabilities 7,016 6,438 Total Current Liabilities 100,136 100,510   Deferred income taxes 505 650 Long-term debt 292 390 Stockholders' Equity 129,626 86,694   Total Liabilities & Stockholders' Equity $ 230,559   $ 188,244

Debt Dollars in millions $10.9 $25.2 $85.9 $0 $20 $40 $60 $80 $100 2004 2005 2006

Stockholders’ Equity Dollars in millions $129.6 $4.6 $86.7 $0 $20 $40 $60 $80 $100 $120 $140 2004 2005 2006

2007 ANNUAL STOCKHOLDERS’ MEETING

EX-99.2

Exhibit 99.2

Introductions Jim Cleary President and Chief Executive Officer Mary Pat Thompson Senior Vice President & Chief Financial Officer

Disclaimer/Forward-Looking Statements This presentation may contain forward-looking statements based on current management expectations. Numerous factors, including those related to market conditions may cause results to differ materially from those anticipated in forward-looking statements. Many of the factors that will determine the Company's future results are beyond the ability of the Company to control or predict. These statements are subject to risks and uncertainties and, therefore, actual results may differ materially. Potential investors should not place undue reliance on forward-looking statements, which reflect management's views only as of the date hereof. The Company undertakes no obligation to revise or update any forward looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

introduction

Mission Statement MWI will be the best resource to the veterinary profession by delivering superior value, efficiency and innovation.

Investment Highlights Favorable industry dynamics driving demand for animal health products Market leading position with national footprint and expansion opportunities Broad product portfolio and value-added services Longstanding relationships with diversified customer and vendor bases Premier sales and marketing franchise Strong and consistent financial performance driven by organic growth Experienced management team

Our Company Leading distributor of animal health products to veterinarians across U.S. 30 years of operating history Over 15,000 veterinary clinics nationwide Over 10,000 products sourced from more than 400 vendors Strong and consistent financial performance

Recent Developments May 8, 2006 – Completed acquisition of substantially all assets of Northland Veterinary Supply Successfully opened Orlando warehouse in June 2006 and relocated to a new Atlanta warehouse in January 2007. We also expanded the size of our Denver, Colorado and Glendale, Arizona distribution centers. Select vendor rebate programs transitioned from annual basis to quarterly or trimester basis Continued expansion of value-added services Follow-on offering of 908,846 shares of common stock in July 2006 November 2006 – Extended Banfield contracts through November 2009

industry overview

Attractive Industry Dynamics Large, fragmented U.S. market with favorable growth characteristics 54,000 practicing veterinarians 27,000 veterinary clinics 400 vendors Diversified customer and vendor bases Distributors play vital role Frequent, small orders Clinics avoid storing and managing inventory Importance of sales representatives Long-term relationships Product information / consultation Face-to-face contact U.S. Animal Health Product Sales 2005 U.S. Animal Health Product Sales By Segment $5.0 + Billion Source: Animal Health Institute, American Veterinary Medical Association, and Company estimates ($ in billions) CAGR ~ 5.5% $5.0 + $4.5 $5.0 $4.7 2002 2003 2004 2005 Companion Animal ~54% Production Animal ~46%

Consists of approximately: 90 million cats 73 million dogs 7 million horses Other pets Increased spending driven by: Human-animal bond Rising numbers of households with pets Focus on animal health / preventative care Technology migration from human health to veterinary medicine Aging pet population Companion Animal Market Large market with attractive growth profile Note: Number of cats, dogs, and horses are for the U.S. only. Source: Dogs and Cats for 2004 – APPMA. 2005-2006 Pet Owner’s Survey. Horses for 2004 – US Equine Market, Brakke Consulting.

Includes cattle, swine, poultry, and other food-producing animals 97 million cattle 61 million swine Spending driven by: Economic decisions Improved productivity / yield Disease prevention Production Animal Market Significant market with volume driven by large order sales Source: USDA Agriculture statistics

Importance of Distributors Customers Vendors Single source for multiple products Timely product delivery Reduced number of vendors Inventory management Product information Consultation Cost-effective access to a fragmented market Logistics and distribution Sales and marketing support Ability to move market share Flexible selling models Distributors

Competitive Landscape Key Competitors (1) Competitive market Competition from both numerous vendors and distributors Competing factors include: Customer relationships Service and delivery Product selection Price e-business capabilities Industry consolidation well under way (1) Excludes vendors and other national, regional, local and specialty distributors.

company overview

The MWI Edge: Leading National Distributor Decentralized distribution network facilitates regional market responsiveness 12 strategically located distribution centers throughout the U.S. 5 pharmacies distributing Rx products to end-users nationwide Same day shipment on 98% of orders placed DO NOT DELETE: E:\Dtp 05\500 Set\545 Series\54581\CURRENT FILE\Artwork\\Artwork\Map.cdr HEADQUARTERS AND WAREHOUSE WAREHOUSE PHARMACY

The MWI Edge: Broad Product Portfolio Over 10,000 products stocked in MWI warehouses Over 7,000 additional products available by special order Continually evaluate product portfolio to improve offerings Key products include: Pharmaceuticals, Vaccines and Parasiticides Diagnostics, Capital Equipment and Supplies Veterinary Pet Food and Nutritional Products

The MWI Edge: 2006 Product Revenue Mix 40% 19% 7% 8% 3% 23% Pharmaceuticals Vaccines Parasiticides Diagnostics Capital Equipment Other Supplies

The MWI Edge: Expansive Vendor Network Sources products from over 400 vendors Provides cost-effective access to large and diverse customer base Serves as a principal distributor for key vendors Length of relationship with many key vendors over 10 years MWI’s size and reach have become increasingly important to its vendor base

Flexible Selling Arrangements – Agency Relationships Do not purchase and take inventory of products Upon receipt of order, transmit order to vendor, who picks, packs and ships order Receive commission payment for soliciting order Agency relationships with several leading animal health product vendors Gross billings of $151.4 million, generating commission revenue of $7.8 million in FY 2006

The MWI Edge: Strong Customer Relationships Corporate Clients Independent Veterinary Practices Often small, privately-held Place at least one order / week Independent veterinary practices and producers account for >80% of our product sales Loyal customer base: Over 66% of sales from accounts over 5 years old Over 79% of sales from accounts over 3 years old Nation’s largest private veterinary practice Customer for over 10 years Highly efficient ordering process Feeders’ Advantage Buying group of several of the largest cattle feeders in U.S. Customer for 10 years Highly efficient ordering process

The MWI Edge: Premier Sales and Marketing Franchise Sales Representatives FYE Sept 30, Dual coverage approach with frequent contact Act as business consultants Continuous training initiatives Performance driven compensation Significant industry experience Direct Marketing Over 450,000 pieces of direct marketing material distributed Comprehensive and specialty catalogs, loyalty programs, product / vendor programs, flyers, order stuffers 265 261 227 190 169 151 69 75 79 93 106 110 82 94 111 134 155 155 2002 2003 2004 2005 2006 12/31/2006 Telesales Reps Field Sales Reps

The MWI Edge: Value-Added Services E-Commerce Platform Technology systems closely integrated with customers’ day-to-day operations E-Commerce Product Sales as a Percent of Total Sales 18% 21% 23% 23% 2004 2005 2006 Q107

The MWI Edge: Value-Added Services Value-added services increase loyalty of customer base E-commerce platform Pharmacy fulfillment SWEEP™ Inventory management system Equipment procurement consultation Special order fulfillment Educational seminars Pet cremation

MWI Growth Strategy Expand Number of Veterinarians Served Offer Innovative, Differentiated Solutions to Veterinarians Increase Share of Spend from Existing Customers Pursue Strategic Acquisitions Expand Agreements with Existing and New Vendors Increase Overall Productivity and Profitability

financial overview

Strong Growth in Revenues Total Revenues ($ in millions) FY 00-06 CAGR 20.7% FYE Sept 30, CAGR 16.8% $195.6 $221.4 $341.7 $394.3 $496.7 $606.2 $137.8 $161.0 $281.2 $0.0 $100.0 $200.0 $300.0 $400.0 $500.0 $600.0 $700.0 2000 2001 2002 2003 2004 2005 2006 Q1 06 Q1 07

Strong Growth in Operating Income Operating Income FYE Sept 30 ($ in millions) * includes the effect of rebate earnings of approximately $2.5 million (pre-tax) earned in fiscal year 2006 that historically would have been earned in our fiscal year 2007 first quarter ended December 31, 2006. ($ in millions) 2000 2001 2002 2003 2004 2005 2006 Q1 06 Q1 07 Management Fee - - $0.1 $0.3 $0.4 $2.5 $0.0 $0.0 $0.0 Depreciation & Amortization 0.8 0.8 0.9 1.0 1.1 1.5 2.0 0.4 0.6 Operating Income 6.4 7.3 7.2 10.2 12.6 15.8 23.7 7.8 7.5 * 0 5 10 15 20 25 2000 2001 2002 2003 2004 2005 2006 Q1 06 Q1 07 Operating Income Depreciation & Amortization Management Fee

Condensed Consolidated Balance Sheets ($ in thousands) $ 188,244 $ 230,559 $ 234,527 Total Liabilities & Stockholders' Equity 86,694 129,626 134,403 Stockholders' Equity 390 292 292 Long-term debt 650 505 460 Deferred income taxes 100,510 100,136 99,372 Total Current Liabilities 6,438 7,016 8,023 Accrued expenses & other current liabilities 69,382 82,561 89,469 Accounts payable $ 24,690 $ 10,559 $ 1,880 Line-of-credit Liabilities $ 188,244 $ 230,559 $ 234,527 Total Assets 1,533 1,772 1,906 Other assets, net 31,383 33,943 33,876 Goodwill & intangibles, net 6,919 7,053 7,600 Property and equipment, net 148,409 187,791 191,145 Total Current Assets 2,493 3,153 2,707 Other current assets Inventories Receivables, net $ 31 $ 37 $ 37 Cash 9/30/2005 9/30/2006 12/31/2006 Assets 89,773 99,518 77,099 98,628 85,083 68,786

Financial Highlights Consistent organic growth Stable, recurring revenue base over 95% consumables Minimal capital expenditure requirements Strong returns on net assets and invested capital Balance sheet provides financial flexibility

conclusion

Investment Highlights Favorable industry dynamics driving demand for animal health products Market leading position with national footprint and expansion opportunities Broad product portfolio and value-added services Longstanding relationships with diversified customer and vendor bases Premier sales and marketing franchise Strong and consistent financial performance driven by organic growth Experienced management team